Day One Biopharmaceuticals Holding Co LLC (17) | Intellectual Property (3)
Browse by Subcategory
Recent Contracts
-
Asset Transfer and License Agreement, effective as of December 16, 2019, by and between DOT Therapeutics-1, Inc. and Millennium Pharmaceuticals, Inc
(Filed With SEC on May 4, 2021)
-
License Agreement for RAF, effective as of December 16, 2019, by and between Sunesis Pharmaceuticals, Inc. and DOT Therapeutics-1, Inc
(Filed With SEC on May 4, 2021)
-
License Agreement, dated February 10, 2021, by and between Merck KGaA, Darmstadt, Germany and Day One Biopharmaceuticals, Inc
(Filed With SEC on May 4, 2021)